Baird Financial Group, Inc. - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 244 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
Baird Financial Group, Inc. ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2022$183,000
-13.7%
19,055
-0.9%
0.00%0.0%
Q2 2022$212,000
-53.8%
19,234
-30.2%
0.00%0.0%
Q1 2022$459,000
-9.5%
27,545
+3.7%
0.00%0.0%
Q4 2021$507,000
-33.8%
26,550
-14.5%
0.00%
-50.0%
Q3 2021$766,000
+230.2%
31,067
+324.1%
0.00%
+100.0%
Q1 2021$232,000
-88.1%
7,325
-82.5%
0.00%
-83.3%
Q4 2020$1,944,000
+77.5%
41,886
+25.9%
0.01%
+50.0%
Q3 2020$1,095,000
+37.4%
33,261
+14.6%
0.00%
+33.3%
Q2 2020$797,000
+140.8%
29,028
+162.8%
0.00%
+50.0%
Q1 2020$331,00011,0450.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 2,674,299$65,948,0005.28%
Ghost Tree Capital, LLC 700,000$17,262,0005.05%
Perceptive Advisors 11,489,772$283,337,0004.12%
Prosight Management, LP 274,761$6,776,0003.73%
Fairmount Funds Management LLC 389,588$9,607,0003.49%
Avoro Capital Advisors LLC 8,500,000$209,610,0003.29%
ACUTA CAPITAL PARTNERS, LLC 374,495$9,235,0003.26%
Ally Bridge Group (NY) LLC 406,986$10,036,0002.95%
Parametrica Management Ltd 146,362$3,609,0002.70%
COMMODORE CAPITAL LP 362,869$8,948,0002.36%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders